ÀÏ×ÓÓÐÇ®lzyq88¹ÙÍø

À´Ô´£ºÃºÌ¼Ô¤ £¬×÷Õߣº ũҵ £¬£º

ÚÀ £¬Ù¯ÏþµÃ·¥ £¬ë¡Á½ÌìÎÒÈ¥³ÇÚòÃíµ´Âí· £¬Ë³±ã³ÔÁ˶ÙÉÙ¸¾Ð»¾« X°×½« £¬ÕæÊÇÀϽá¹÷¸öŶ£¡½²Õæ°¡ £¬Õâ¸ö¹¤¾ß £¬ÍâµØÈËÀ´ÉϺ£ £¬Ê®Óа˾Żá¸ãÎðÇåˬ¡£Æäʵ°¡ £¬°¢À­ÉϺ£Äþ½²ÆðÀ´ £¬ë¡¸öôÊÇ´ÓС³Ôµ½´ó £¬ÏþµÃÀïÍ·µÄÃŵÀ £¬»¹ÕæÊÇÓеãÒâ˼¡£

ÉÙ¸¾Ð»¾« X°×½« £¬Ãû×ÖÀïÏá¾ÍÓÐÎÄÕÂ

ÎÒ¸úÙ¯½²Å¶ £¬ë¡¸öÃû×ÖÕ§Ò»Ìý £¬ÍâµØÈË¿ÉÄÜ»á¾õµÃÓеãÞÖ¿Ú¡£ÆäʵËüÊÇ¡°ÉÕºõºõµÄз¾«ºÍз°×½«¡±µÄÒâ˼¡£½²°×ÁË £¬¾ÍÊÇÓÃÏʵÃÀ´Ð·»ÆÐ·¸à £¬¼ÓÉÏзÈâ×öµÄµ÷ζ½´¡£àåÍ·ÊÇɶ·¥ £¿¾ÍÊÇ¡°ÏÊ¡±×ÖÍ·£¡ÉϺ£Äþ³Ô¹¤¾ß £¬×î½²¾¿¸ö¾ÍÊÇÏÊͷζ£¡

ÚÀ £¬Ù¯ÏþµÃ·¥ £¬Õâ¸öÉÙ¸¾Ð»¾« X°×½«µÄ¡°ÏÊ¡± £¬ÆäʵÓÐÁ½¸öÌõÀí¸öŶ¡£

    Ïà¹ØÍ¼Æ¬
  • Ò»¸öÊÇʳ²ÄµÄÏÊ£ºÐ·»ÆÐ·¸àÊÇÖ÷½Ç £¬Ò»¶¨ÒªÓÃÐÂÏÊó¦Ð· £¬ÌرðÊÇÇïÌì´óբз·Ê¸ö³½¹â £¬ë¡¸öζµÀ²Å¹»Õý×Ú¡£
  • Ò»¸öÊǵ÷ζµÄÏÊ£º°¢À­ÉϺ£È˽²¾¿¡°ÏÊÖдøÌ𡱠£¬ËùÒÔÀïÍ·»¹»á·ÅµãÌÇ £¬ë¡¸öÌð¶ÈÒªÄÃÄóµÃÀϵó×ê £¬Ì«¶à¾ÍÄåÉ·ÍÑÁË £¬Ì«ÉÙÓÖûÒâ˼¡£

³Ô·¨Óн²¾¿ £¬Ò…ÂҸ㣡

½²µ½³Ô·¨Å¶ £¬ÎÒ¸úÙ¯½² £¬Ù¯ÒªÊǵÚÒ»´Î³Ô £¬»¹ÕæÒªÑ§µãÃŵÀ £¬²ÅÏþµÃËüµÄºÃ¡£

Ò»°ãÀ´Ëµ £¬ÉÙ¸¾Ð»¾« X°×½«ÊÇÓÃÀ´Åä°×·¹µÄ¡£Ù¯ÏëÏë°¡ £¬°×»¨»¨µÄÃ×·¹ £¬ë¡µãз½´Ò»°è £¬ÄÇζµÀÒ»»ìÏý £¬Õæ¸öÊÇÌìÌ𡣡ËäȻŶ £¬Ò²ÓÐЩÀÏ÷Òϲ»¶ÄÃÀ´ÅäÃæ £¬»òÕßÖ±½ÓÍ¿ÔÚ´ó±ýÉϳÔ £¬Ò²ÊDZðÓÐÒ»·¬×Ìζ¡£

͵͵¸æËßٯŶ£ºÓÐÒ»´ÎÎÒÀÏÔçÎʹýÒ»¸ö×öÉÙ¸¾Ð»¾« X°×½«µÄÀÏ·¨Ê¦ £¬Ëû½² £¬ë¡¸ö½´ÒªºÃ³Ô £¬Òªº¦ÊÇ»ðºò¡£Ð·»ÆÒªÓÃС»ðÂýÂý°¾ £¬¼±²»µÃ £¬»ðÍ·Ò»´ó¾ÍºýÉ·ÍÑÁË¡£ÁíÓÐŶ £¬×îºóÒ»¶¨Òª¼ÓµãÉÜÐËÀϾÆ £¬ë¡¸ö¾ÆÏãÒ»³öÀ´ £¬¾ÍÏñ»­Áúµã¾¦¡£ Ïà¹ØÍ¼Æ¬

ÏÊͷζÀïÍ· £¬ÓÐÀÏÉϺ£µÄ¹ÊÊÂ

Ù¯ÏþµÃ·¥ £¬ÉÙ¸¾Ð»¾« X°×½«ÆäʵÊÇÀÏÔç³½¹âÉϺ£ÅªÌÃÀïÏáµÄÒ»ÖÖ¼Ò³£Î¶µÀ £¬ØÊºóÂýÂýÉý¼¶³ÉÁËÃû²Ë¡£ÎÒСʱºò £¬¼ÒÀïÌõ¼þ»¹Ëã²»´í £¬Ã¿ÄêÇïÌìÀÏÔçÒ¯Êå»áÂò¼¸Ö»´óբз»ØÀ´ £¬ÕôºÃÒÔºó £¬°Ñз»ÆºÍз¸à¹Î³öÀ´ £¬°èµãÖíÓͺͽ´ÓÍ £¬×ö³ÉһС¹Þз½´¡£ë¡¸öʱºò·¥ÏñÏÖÔÚÕâÑù £¬É¶¶¼ÓÐÂô £¬¶¼ÊÇ×Ô¼ºÈëÊÖ×ö¡£

ë¡ÌìÒ¹¿ìµã £¬ÎÒ»¹¼ÇµÃ £¬ÅªÌÃÀïÏáÁÚ¾Ó¼ÒµÄÒÌÂèÒ»Îŵ½Õâ¸öζµÀ £¬¾Í»áÅܹýÀ´ÎÊ£º¡°Ù¯¼ÒÓÖÔÚ×öɶÎïʰ¡ £¬ÏãÉ·ÍÑÁË£¡¡±ÎÒ°¢ÄイŶ £¬ë¡¸öζµÀ¾ÍÊÇÉϺ£ÀÏ»ù´¡µÄ¡°ÏÊͷζ¡± £¬ÊÇ´ÓС³Ôµ½´óµÄÓ°Ïó¡£


ËùÒÔ˵ £¬½²µ½ÕâÀïŶ £¬Ù¯¿ÉÄÜÒªÎÊÁË£º

ÎÊ£ºÙ¯ÏþµÃÄÄÀïµÄÉÙ¸¾Ð»¾« X°×½«×îºÃ³Ô·¥ £¿

´ð£ºÕÕÎÒ¿´À´Å¶ £¬³ÇÚòÃíÀïÏáÓм¸¼ÒÀÏ×ֺŠ£¬Î¶µÀ»¹ËãÕý×Ú¡£²»¹ýÂï £¬ÕæÕý¶¥ßÉßɵÄ £¬ÕÕ¾É×Ô¼º¼ÒÀï×öµÄ£¡Ù¯ÒªÊǿϻ¨µãʱ¼ä £¬ÂòµãÐÂÏʵĴóբз £¬Æ¾¾ÝÀÏ·¨Ê¦µÄ°ì·¨ £¬×Ô¼ºÈëÊÖÊÔÊÔ¿´ £¬ë¡ÖÖÂú×ã¸Ð £¬²ÅÊÇÕæÕýÉϺ£Äþ¸öÉú»îζµÀ£¡

±êÇ©£º

  • ÉÙ¸¾Ð»¾« X°×½«
  • ÉϺ£ÏÊͷζ
  • з½´
  • ÀÏÉϺ£Î¶µÀ
  • ³ÇÚòÃíС³Ô

¡¶¼æÖ°¿Õ½ã΢Ðźš·

΢³É¶¼±¨µÀлªÎÄÐù£¨601811.SH£©2ÔÂ10ÈÕͨ¸æ £¬¹«Ë¾¶­Ê»ᵱÌìÊÕµ½¹«Ë¾¶­Ê¡¢×ܾ­ÀíÀîÇ¿µÄÊéÃæ´ÇÈκ¯¡£ÀîÇ¿ÒòÊÂÇéµ÷½âÔ­Òò £¬´ÇÈ¥µÚÎå½ì¶­Ê»ᶭÊ¡¢×ܾ­ÀíµÈÖ°Îñ £¬´ÇÈκóÀîÇ¿½«²»ÔÚ¹«Ë¾¼°Æä×Ó¹«Ë¾µ£µ±ÈκÎÖ°Îñ¡£

¡¶92 £¬94 £¬95 £¬98¡·

Fenebrutinib×é³£¼ûµÄ²»Á¼Ê¼þ£¨±¬·¢ÂÊ¡Ý10%£©ÓëOcrevusÏ൱£ºÑ¬È¾£¨67.0% vs 70.9%£©¡¢¶ñÐÄ£¨12.0% vs 7.1%£©ºÍ³öѪ£¨10.2% vs 8.1%£©¡£ÔÚFenebrutinib×éÖÐ £¬¸Îø¶ÌÔÝÐԺͿÉÄæÐÔÉý¸ß¸üΪ³£¼û£¨13.3% vs 2.9%£© £¬ËùÓв¡ÀýÔÚÍ£Ò©ºó¾ùÒÑȬÓú¡£Î´ÊӲ쵽DZÔÚÑÏÖØ¸ÎËðÉË¡£Fenebrutinib×éºÍOcrevus×éµÄÑÏÖØ²»Á¼Ê¼þ±¬·¢ÂÊ»®·ÖΪ19.1%ºÍ18.9% £¬Òò´Ëµ¼ÖµÄÖÐ;Í˳öÖÎÁƱÈÀý»®·ÖΪ4.3%ºÍ3.0%¡£Fenebrutinib×éºÍOcrevus×éµÄËÀÍö±ÈÀý»®·ÖΪ1.4%ºÍ0.2% £¬¾­Ñо¿ÈËÔ±ÆÀ¹À £¬ÕâЩËÀÍöʼþ¾ùÓëÒ©ÎïÎÞ¹Ø £¬ÇÒδÊӲ쵽ʱ¼ä»ò²¡ÒòµÄ¼ÍÂÉ¡£Á÷Ðв¡Ñ§Ñо¿±êÃ÷ £¬MS»¼ÕßµÄÖÂËÀÂʸßÓÚÆÕͨÈËȺ¡£

¡¶´óÅíׯÓÐÄêÇáµÄÂð¡·

Ãæ¶ÔÖÖÖÖ×÷Òµ¡°ÈÎÎñ¡± £¬¼Ò³¤ÃǸ÷ÏÔÉñͨ £¬ÓеÄÇ××ÔÉÏÕó×ÊÖú £¬ÓеÄÉõÖÁÕÒÀ´ÁËAI¡°ÍâÔ®¡±¡£

ÍøÕ¾µØÍ¼